← Back to All Trades

GILD

Congressional & insider trading activity

51
Total Trades
8
Traders
12 / 39
Buys / Sells
Distributing
Congress Sentiment
Buy Volume: $265,000 Sell Volume: $240,000

Recent Trades

Date Trader Type Amount Filed
2026-09-10 Dickinson Andrew D Insider SELL - 2026-09-11
2026-09-10 Mercier Johanna Insider SELL - 2026-09-11
2026-09-10 Cain Wettan Keeley M Insider SELL - 2026-09-11
2026-09-10 Berger Dietmar Insider SELL - 2026-09-11
2026-09-10 O'Day Daniel Patrick Insider SELL - 2026-09-11
2026-09-01 O'Day Daniel Patrick Insider SELL - 2026-09-02
2026-08-26 WELTERS ANTHONY Insider SELL - 2026-08-27
2026-08-20 Bluestone Jeffrey Insider SELL - 2026-08-21
2026-08-17 Dickinson Andrew D Insider SELL - 2026-08-18
2026-08-17 Mercier Johanna Insider SELL - 2026-08-18
2026-08-10 Cain Wettan Keeley M Insider SELL - 2026-08-11
2026-08-03 O'Day Daniel Patrick Insider SELL - 2026-08-04
2026-07-15 Mercier Johanna Insider SELL - 2026-07-16
2026-07-15 Dickinson Andrew D Insider SELL - 2026-07-16
2026-07-01 O'Day Daniel Patrick Insider SELL - 2026-07-02
2026-06-15 Dickinson Andrew D Insider SELL - 2026-06-16
2026-06-15 Mercier Johanna Insider SELL - 2026-06-16
2026-06-10 O'Day Daniel Patrick Insider SELL - 2026-06-11
2026-06-10 Dickinson Andrew D Insider SELL - 2026-06-11
2026-06-10 Berger Dietmar Insider SELL - 2026-06-11

Showing 20 of 51 trades

Top Institutional Holders SEC 13F Filings

Quarterly institutional ownership from 13F-HR filings

Institution Shares Value Report Date
Vanguard Group Inc 121,097,336 $14,863,487,020 2025-12-31
FMR LLC 66,870,816 $8,448,459,045 2026-06-30
BlackRock Inc 120,632,023 $8,276,563,065 2024-06-30
State Street Corp 61,216,552 $7,734,099,180 2026-06-30
Invesco Ltd 39,819,151 $5,030,751,525 2026-06-30
Morgan Stanley 24,004,354 $3,032,710,535 2026-06-30
JPMorgan Chase & Co 20,820,621 $2,630,269,146 2026-06-30
Wellington Management Group 12,699,683 $1,604,477,952 2026-06-30
Goldman Sachs Group Inc 10,778,294 $1,361,729,795 2026-06-30
Dimensional Fund Advisors 7,899,794 $998,068,365 2026-06-30

Trade-Event Timing Trades near material events

Trades within 7 days before or 3 days after 8-K filings

O'Day Daniel Patrick SELL 1d before Results of Operations and Financial Condition (2026-08-04)
Mercier Johanna SELL 1d after Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Other Events (2026-05-14)
Dickinson Andrew D SELL 1d after Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Other Events (2026-05-14)
MANWANI HARISH SELL 7d before Results of Operations and Financial Condition (2026-05-07)
MANWANI HARISH SELL same day as Submission of Matters to a Vote (2026-04-30)
O'Day Daniel Patrick SELL 2d before Submission of Matters to a Vote (2026-04-30)
MANWANI HARISH SELL 2d after Regulation FD Disclosure; Other Events (2026-04-28)
O'Day Daniel Patrick SELL same day as Regulation FD Disclosure; Other Events (2026-04-28)
Mercier Johanna SELL 5d before Entry into a Material Definitive Agreement; Regulation FD Disclosure (2026-02-22)

Corporate Events SEC 8-K Filings

Material corporate events reported to the SEC

Results of Operations and Financial Condition 2.02,9.01

GILEAD SCIENCES, INC.

2026-08-04 SEC Filing →
Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Other Events 1.01,2.03,8.01,9.01

GILEAD SCIENCES, INC.

2026-05-14 SEC Filing →
Results of Operations and Financial Condition 2.02,9.01

GILEAD SCIENCES, INC.

2026-05-07 SEC Filing →
Submission of Matters to a Vote 5.07,9.01

GILEAD SCIENCES, INC.

2026-04-30 SEC Filing →
Regulation FD Disclosure; Other Events 7.01,8.01,9.01

GILEAD SCIENCES, INC.

2026-04-28 SEC Filing →
Entry into a Material Definitive Agreement; Regulation FD Disclosure 1.01,7.01,9.01

GILEAD SCIENCES, INC.

2026-02-22 SEC Filing →

Major Shareholders SEC 13D/13G Filings

Beneficial owners holding 5%+ of outstanding shares

Owner Shares Ownership Filing Type Filing Date
GILEAD SCIENCES, INC. SCHEDULE 13D/A
100 100.0% SCHEDULE 13D/A 2026-04-28
GILEAD SCIENCES, INC. SCHEDULE 13D/A
39,691,649 35.0% SCHEDULE 13D/A 2025-03-05
GILEAD SCIENCES, INC. SCHEDULE 13D/A
39,691,649 35.0% SCHEDULE 13D/A 2025-02-20
GILEAD SCIENCES, INC. SCHEDULE 13D/A
31,424,760 29.7% SCHEDULE 13D/A 2025-07-15
GILEAD SCIENCES, INC. SCHEDULE 13D/A
4,505,391 29.0% SCHEDULE 13D/A 2025-08-12
GILEAD SCIENCES, INC. SCHEDULE 13D/A
31,424,760 25.6% SCHEDULE 13D/A 2025-11-05
GILEAD SCIENCES, INC. SCHEDULE 13D/A
4,977,089 25.1% SCHEDULE 13D/A 2026-05-27
Gilead Sciences, Inc. SCHEDULE 13D/A
31,424,760 24.7% SCHEDULE 13D/A 2026-08-07
GILEAD SCIENCES, INC. SCHEDULE 13G/A
14,517,678 19.9% SCHEDULE 13G/A 2026-02-12
GILEAD SCIENCES, INC. SCHEDULE 13G/A
10,613,944 19.9% SCHEDULE 13G/A 2025-08-14